The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...
Panelists discuss how the greatest unmet needs include addressing poor outcomes in specific subsets like TP53-mutant disease, managing the increasingly older population with secondary mutations, and ...
Please provide your email address to receive an email when new articles are posted on . Albliwi, a second-year resident at Cleveland Clinic, highlighted the study, which was a retrospective cohort ...
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers and is characterized by the rapid growth of immature ...
A study revealed that RBPMS supports leukemia cell survival and progression. The protein upregulates FOXO1, leading to ...
Bio-Path Holdings, Inc. announced positive developments in its ongoing clinical trials, including the Phase 1/1b trial of BP1001-A for solid tumors and a Phase 2 study of prexigebersen in Acute ...
Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...
SEATTLE, WA / ACCESS Newswire / March 10, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results